XML 57 R40.htm IDEA: XBRL DOCUMENT v3.19.1
Collaboration Agreements - Royalty Revenues under the Collaboration Agreement with GSK (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 29, 2019
Mar. 30, 2018
Collaboration Agreement with GlaxoSmithKline    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Royalties accruing to GSK $ 7,282 $ 5,125
GSK | Collaborative Arrangement with Ipsen    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Percent of royalty on net sale 3.00%